Invesaro

Stocks Comparison

Becton Dickinson vs Dexcom: revenue, profit, margins and growth compared

Becton Dickinson brought in $21.8B of revenue in fiscal 2025, Dexcom $4.7B in fiscal 2025. Revenue changed by +8.2% at Becton Dickinson and +15.6% at Dexcom on the year before, so Dexcom grew faster. Becton Dickinson kept 7.7% of its revenue as net profit, Dexcom 17.9%. Free cash flow was $2.7B at Becton Dickinson and $1.1B at Dexcom.

Side by side, latest fiscal year

BDXDXCM
Fiscal year endedFY2025 (September 30, 2025)FY2025 (December 31, 2025)
Revenue$21.8B$4.7B
Revenue growth+8.2%+15.6%
Net income$1.7B$836.3M
Net margin7.7%17.9%
Free cash flow$2.7B$1.1B
Free cash flow margin12.2%23.1%
Earnings per share (diluted)$5.82$2.09
Cash$567M$917.7M
Debt$17.6Bn/a
Price to earnings31.641.4
Market value$50.1B$32.7B
Dividend yield2.26%n/a
Rank by revenue in sector#27 of 523 · Health care#65 of 523 · Health care

Over the years

Revenue
BDX FY2018: $16BBDX FY2019: $17.3BBDX FY2020: $16.1BBDX FY2021: $19.1BBDX FY2022: $18.9BBDX FY2023: $19.4BBDX FY2024: $20.2BBDX FY2025: $21.8BDXCM FY2018: $1BDXCM FY2019: $1.5BDXCM FY2020: $1.9BDXCM FY2021: $2.4BDXCM FY2022: $2.9BDXCM FY2023: $3.6BDXCM FY2024: $4BDXCM FY2025: $4.7BFY18FY19FY20FY21FY22FY23FY24FY25
BDX $21.8BDXCM $4.7B
Net income
BDX FY2018: $311MBDX FY2019: $1.2BBDX FY2020: $874MBDX FY2021: $2.1BBDX FY2022: $1.8BBDX FY2023: $1.5BBDX FY2024: $1.7BBDX FY2025: $1.7BDXCM FY2018: -$127.1MDXCM FY2019: $101.1MDXCM FY2020: $549.7MDXCM FY2021: $216.9MDXCM FY2022: $341.2MDXCM FY2023: $541.5MDXCM FY2024: $576.2MDXCM FY2025: $836.3MFY18FY19FY20FY21FY22FY23FY24FY25
BDX $1.7BDXCM $836.3M
Net margin
BDX FY2018: 1.9%BDX FY2019: 7.1%BDX FY2020: 5.4%BDX FY2021: 10.9%BDX FY2022: 9.4%BDX FY2023: 7.7%BDX FY2024: 8.4%BDX FY2025: 7.7%DXCM FY2018: -12.3%DXCM FY2019: 6.8%DXCM FY2020: 28.5%DXCM FY2021: 8.9%DXCM FY2022: 11.7%DXCM FY2023: 14.9%DXCM FY2024: 14.3%DXCM FY2025: 17.9%FY18FY19FY20FY21FY22FY23FY24FY25
BDX 7.7%DXCM 17.9%
Revenue growth
BDX FY2019: +8.2%BDX FY2020: -7.0%BDX FY2021: +19.0%BDX FY2022: -1.4%BDX FY2023: +2.7%BDX FY2024: +4.2%BDX FY2025: +8.2%DXCM FY2019: +43.1%DXCM FY2020: +30.5%DXCM FY2021: +27.1%DXCM FY2022: +18.8%DXCM FY2023: +24.5%DXCM FY2024: +11.3%DXCM FY2025: +15.6%FY19FY20FY21FY22FY23FY24FY25
BDX +8.2%DXCM +15.6%
Free cash flow
BDX FY2018: $2BBDX FY2019: $2.4BBDX FY2020: $2.8BBDX FY2021: $3.5BBDX FY2022: $1.5BBDX FY2023: $2.1BBDX FY2024: $3.1BBDX FY2025: $2.7BDXCM FY2018: $56.1MDXCM FY2019: $134.5MDXCM FY2020: $276.6MDXCM FY2021: $53.3MDXCM FY2022: $304.7MDXCM FY2023: $511.9MDXCM FY2024: $630.7MDXCM FY2025: $1.1BFY18FY19FY20FY21FY22FY23FY24FY25
BDX $2.7BDXCM $1.1B

Fiscal years as each company reports them; the two may end in different months.

Questions about Becton Dickinson and Dexcom

Which is bigger by revenue, Becton Dickinson or Dexcom?

Becton Dickinson is bigger by revenue: $21.8B in fiscal 2025, against $4.7B for Dexcom in fiscal 2025.

Which keeps more of its revenue as profit, Becton Dickinson or Dexcom?

Becton Dickinson had a net margin of 7.7% in fiscal 2025; Dexcom had 17.9% in fiscal 2025.

Which grew revenue faster, Becton Dickinson or Dexcom?

In their latest fiscal years revenue changed by +8.2% at Becton Dickinson and +15.6% at Dexcom.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies